Journal
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING
Volume 18, Issue 9, Pages 945-960Publisher
OXFORD UNIV PRESS
DOI: 10.1093/ehjci/jex094
Keywords
arterial hypertension; target organ damage; non-invasive cardiovascular imaging; cardiovascular risk; prognosis
Funding
- Medical Research Council [MC_PC_13090] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0509-10222, NF-SI-0514-10011] Funding Source: researchfish
- MRC [MC_PC_13090] Funding Source: UKRI
Ask authors/readers for more resources
Arterial hypertension (HTN) accounts for the largest amount of attributable cardiovascular (CV) mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by HTN represents an independent determinant of CV risk and the identification of target organ damage (TOD) is recommended to further reclassify patients' risk. Non-invasive CV imaging is progressively being used and continues to provide new technological opportunities to TOD evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of non-invasive imaging tests in the growing population of hypertensive patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available